Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Hemophilia AHemophilia B
Trial Locations (19)

10065

Weill Cornell Medical College, New York

11040

Long Island Jewish Medical Center, New Hyde Park

14222

Hemophilia Center of Western New York - Pediatric, Buffalo

14621

Mary M. Gooley Hemophilia Center, Inc., Rochester

19104

Children's Hospital of Philadelphia, Philadelphia

20007

Georgetown University Hospital, Washington D.C.

30322

Emory University Hemophilia Program Office, Atlanta

40536

University of Kentucky Hemophilia Treatment Center, Lexington

44308

Children's Hospital Medical Center of Akron, Akron

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48202

Henry Ford Hospital Adult Hemophilia and Thrombosis Treatment Center, Detroit

60611

Northwestern University, Chicago

73104

Oklahoma Center for Bleeding Disorders, Oklahoma City

77030

Gulf States Hemophilia and Thrombophilia Center, Houston

80045

Mountain States Regional Hemophilia and Thrombosis Center, Aurora

91010

City of Hope National Medical Center, Duarte

02115

Boston Hemophilia Center- Children's Hospital, Boston

07112

Newark Beth Israel Medical Center, Newark

00936

Puerto Rico Hemophilia Treatment Center, San Juan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CSL Behring

INDUSTRY

collaborator

University of Pennsylvania

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT00936845 - Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study | Biotech Hunter | Biotech Hunter